ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
FY 2024 Preliminary Unaudited Total Revenue of Approximately $417-425 Million, Exceeding Previous Guidance of $415 Million
ADMA Biologics
Manufacturing · New Jersey, United States · 624 Employees
View Company Info for Free
About
Headquarters
465 State Rt 17, Ramsey, New Jersey, 07446, Uni...Phone Number
(201) 478-5552Website
www.admabiologics.comRevenue
$283.2 MillionStock Symbol
ADMAIndustry
Most Recent Scoops
Nov 21 2024
Award
Nov 7 2024
Earnings
Highlights
$462.6M
Total Funding Amount
$100M
Most Recent Funding Amount
15
Number of Funding Rounds
Who is ADMA Biologics
Founded in 2004, ADMA Biologics is a commercial biopharmaceutical company that focuses on manufacturing, marketing, and developing products for immunodeficient patients at risk for infection. The company is headquartered in Ramsey, New Jersey.Explore more
ADMA Biologics Org Chart
Is ADMA Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ADMA Biologics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once ADMA Biologics has new funding data
Check if ADMA Biologics has recently received funding, and reach out quickly before it becomes old news!
ADMA Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at ADMA Biologics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ADMA Biologics recently announced quarterly report
Click to see if ADMA Biologics had a recent Job posting/layoffs
Product Launch: Get notified when ADMA Biologics launches new products
Recommended Actions
Reach out to Masked Content who joined ADMA Biologics as Masked Content
Find 3 more new buyers
Compare Similar Companies to ADMA Biologics
Compare insights from companies similar to ADMA Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ADMA Biologics
$283.2M
624
ADMA Biologics financials insights
Gather financial insights about ADMA Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
ADMA Biologics Employee Growth Rate
View ADMA Biologics’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
ADMA Biologics Tech Stack
A closer look at the technologies used by ADMA Biologics
Most Recent Scoops
Nov 21 2024
Award
Award, Finance
Nov 7 2024
Earnings
Earnings
Nov 7 2024
Earnings
Earnings
Nov 7 2024
Earnings
Earnings
Oct 21 2024
Open Position
ADMA Biologics News & Media
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025
RAMSEY, N.J. and BOCA RATON, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ADMA’s presentation will be on Monday, January 13, 2025, at 10:30 a.m. PT.ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares CapitalSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ:ADMA) on behalf of ADMA Biologics stockholders. Our investigation concerns whether ADMA Biologics has violated the federal securities laws and/or engaged in other unlawful business practices.
Read more news
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding ADMA Biologics
Founded in 2004, ADMA Biologics is a commercial biopharmaceutical company that focuses on manufacturing, marketing, and developing products for immunodeficient patients at risk for infection. The company is headquartered in Ramsey, New Jersey.... Read More
